In comparisons with the expression levels of K2P5.1, those of K2P3.1 were markedly lower in the CD4+ T cells, and no significant differences were found between the normal and IBD model mice (n = 4, p = 0.1252) (Figure 9A). This evidence concerns the gene CD4 and inflammatory bowel disease.